Our notion that the sensitivity of CML cells to hydroxyurea is independent of STAT5 agrees with previous results that could not show a linkage between STAT5 activity and the sensitivity of CML cells to hydroxyurea [43]. The gene discussed is STAT5A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.